From 2016: Dana-Farber nutritionist Stacy Kennedy, MPH, RD, CSO, discusses the optimal foods for cancer patients and answers questions about the latest food fads and myths.

Melissa and Noel were both diagnosed with stage III breast cancer in their 30s. Matched through Dana-Farber's SoulMates program, Noel was tasked with mentoring Melissa through her treatment, which began in early 2015. Now, as both women are finished with active treatment, the mentor-mentee relationship has blossomed into a friendship beyond breast cancer.

Lisa Diller, MD, chief medical officer of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, answers questions about the unique needs and concerns for patients and families transitioning off treatment, including fertility issues, follow-up care, and emotional challenges young survivors face.

From 2016: Ursula Matulonis, MD, medical director of the Gynecologic Oncology Program in the Susan F. Smith Center for Women's Cancers, joins medical oncologist Alexi Wright, MD, MPH, and radiation oncologist Larissa Lee, MD, for a discussion on the latest information on the prevention, treatment and research of cervical cancer.

From 2016: Eric Winer, MD, director of the Breast Oncology Program in the Susan F. Smith Center for Women's Cancers, discusses the latest treatments for metastatic breast cancer as well as information on emerging clinical trials.

From 2016: Irene Ghobrial, MD, and Matthew Davids, MD, from Dana-Farber's Hematologic Oncology Treatment Center discuss the latest treatment advances and research in multiple myeloma, leukemia, and more. They also share highlights from the 2015 American Society of Hematology (ASH) Annual Meeting.

From 2016: Ursula Matulonis, MD, Panos Konstantinopoulos, MD, PhD, and Susana Campos, MD, MPH, from the Gynecologic Oncology Program at the Susan F. Smith Center for Women’s Cancers discuss the latest treatment options for ovarian cancer as well as answer patient questions about side effects and new clinical trials.

Huma Rana, MD, clinical director of Dana-Farber's Center for Cancer Genetics and Prevention, gives an overview of the link between genetics and women's cancers, and why certain women have a higher risk for developing disease.

David Rosenthal, MD, former clinical director of Dana-Farber's Leonard P. Zakim Center for Integrative Therapies, discusses acupuncture, meditation, yoga, massage, and other forms of integrative therapy used to ease cancer-related symptoms and side effects.